BARCLAYS PLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,657
-69.5%
437,642
-9.4%
0.00%
-75.0%
Q2 2023$12,001
+1.0%
483,082
-38.9%
0.01%
+60.0%
Q1 2023$11,883
+41.5%
790,093
+11.3%
0.01%
+25.0%
Q4 2022$8,400
-99.8%
710,068
+19.9%
0.00%0.0%
Q3 2022$3,505,000
+150.2%
592,129
+79.6%
0.00%
+300.0%
Q2 2022$1,401,000
+5.0%
329,769
+135.1%
0.00%0.0%
Q1 2022$1,334,000
-83.9%
140,291
-67.9%
0.00%
-50.0%
Q4 2021$8,300,000
+148.8%
436,790
+335.8%
0.00%0.0%
Q3 2021$3,336,000
+249.0%
100,231
+306.7%
0.00%
Q2 2021$956,000
-83.6%
24,643
-79.7%
0.00%
-100.0%
Q1 2021$5,847,000
+83.7%
121,309
+98.3%
0.00%
+50.0%
Q4 2020$3,183,000
-75.3%
61,189
-87.3%
0.00%
-75.0%
Q3 2020$12,898,000
-28.3%
482,016
-47.8%
0.01%
-42.9%
Q2 2020$17,998,000
+112.5%
923,949
+7.3%
0.01%
+100.0%
Q1 2020$8,471,000
-3.8%
860,919
+8.5%
0.01%
+40.0%
Q4 2019$8,807,000
+867.8%
793,422
+389.1%
0.01%
+400.0%
Q3 2019$910,000
+59.9%
162,212
+146.7%
0.00%
Q2 2019$569,000
+292.4%
65,763
+264.5%
0.00%
Q1 2019$145,000
-31.0%
18,041
-64.8%
0.00%
Q4 2018$210,000
+50.0%
51,258
+106.0%
0.00%
Q3 2018$140,000
+11.1%
24,881
+159.6%
0.00%
Q2 2018$126,000
-61.9%
9,583
-58.9%
0.00%
Q1 2018$331,000
+255.9%
23,304
+107.1%
0.00%
Q4 2017$93,000
-69.7%
11,251
-56.6%
0.00%
Q3 2017$307,000
-43.5%
25,921
-52.1%
0.00%
-100.0%
Q2 2017$543,000
+5933.3%
54,077
+6559.7%
0.00%
Q1 2017$9,000
-10.0%
812
-61.6%
0.00%
Q4 2016$10,000
+25.0%
2,113
+127.2%
0.00%
Q3 2016$8,000930
+2168.3%
0.00%
Q2 2016$0
-100.0%
41
-99.7%
0.00%
Q1 2016$97,000
+4750.0%
12,075
+6571.3%
0.00%
Q4 2015$2,000
-88.9%
181
-90.0%
0.00%
Q3 2015$18,000
-82.5%
1,814
-71.7%
0.00%
Q2 2015$103,000
+18.4%
6,420
+9.4%
0.00%
Q1 2015$87,000
-96.8%
5,866
-96.8%
0.00%
-100.0%
Q4 2014$2,753,000
+19564.3%
183,551
+12369.5%
0.00%
Q3 2014$14,000
+250.0%
1,472
+263.5%
0.00%
Q2 2014$4,0000.0%405
-40.6%
0.00%
Q1 2014$4,000
+300.0%
682
+97.7%
0.00%
Q4 2013$1,000
-66.7%
345
-40.6%
0.00%
Q3 2013$3,000
-25.0%
581
-13.3%
0.00%
Q2 2013$4,0006700.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders